![Frontiers | IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells Frontiers | IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells](https://www.frontiersin.org/files/Articles/880412/fimmu-13-880412-HTML/image_m/fimmu-13-880412-g001.jpg)
Frontiers | IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells
![Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction | Nature Communications Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-017-02312-7/MediaObjects/41467_2017_2312_Fig1_HTML.jpg)
Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction | Nature Communications
![Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells | Clinical and Translational Allergy | Full Text Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells | Clinical and Translational Allergy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13601-018-0213-z/MediaObjects/13601_2018_213_Fig1_HTML.png)
Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells | Clinical and Translational Allergy | Full Text
![Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial - The Lancet Gastroenterology & Hepatology Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/8ead1bf4-7673-461f-a92e-ab643a4603f4/gr1_lrg.gif)
Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial - The Lancet Gastroenterology & Hepatology
![The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab | Nature Communications The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-13815-w/MediaObjects/41467_2019_13815_Fig1_HTML.png)
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab | Nature Communications
![Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy | Nature Communications Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33176-1/MediaObjects/41467_2022_33176_Fig1_HTML.png)